Abstract
MALDI-TOF Mass Spectrometry in Serum for the Follow-up of Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Combination Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have